CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease.
CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease.
复制标题
DOI:
10.1038/s41467-021-27385-3
复制
发表时间:
2021-12-09
影响因子:
16.6
通讯作者:
Schnabl B
中科院分区:
文献类型:
--
作者:
Duan Y;Chu H;Brandl K;Jiang L;Zeng S;Meshgin N;Papachristoforou E;Argemi J;Mendes BG;Wang Y;Su H;Sun W;Llorente C;Hendrikx T;Liu X;Hosseini M;Kisseleva T;Brenner DA;Bataller R;Ramachandran P;Karin M;Fu W;Schnabl B
Complement receptor of immunoglobulin superfamily (CRIg) is expressed on liver macrophages and directly binds complement component C3b or Gram-positive bacteria to mediate phagocytosis. CRIg plays important roles in several immune-mediated diseases, but it is not clear how its pathogen recognition and phagocytic functions maintain homeostasis and prevent disease. We previously associated cytolysin-positive Enterococcus faecalis with severity of alcohol-related liver disease. Here, we demonstrate that CRIg is reduced in liver tissues from patients with alcohol-related liver disease. CRIg-deficient mice developed more severe ethanol-induced liver disease than wild-type mice; disease severity was reduced with loss of toll-like receptor 2. CRIg-deficient mice were less efficient than wild-type mice at clearing Gram-positive bacteria such as Enterococcus faecalis that had translocated from gut to liver. Administration of the soluble extracellular domain CRIg–Ig protein protected mice from ethanol-induced steatohepatitis. Our findings indicate that ethanol impairs hepatic clearance of translocated pathobionts, via decreased hepatic CRIg, which facilitates progression of liver disease. CRIg is expressed on liver macrophages and binds Gram-positive bacteria to mediate phagocytosis, but it is not clear how its phagocytic functions contribute to liver homeostasis or disease. Here the authors report that ethanol impairs hepatic clearance of translocated pathobionts, via decreased hepatic CRIg, which facilitates progression of alcoholic liver disease.
登录
查看更多内容
影响因子:
4.6
作者:
Bankhead P;Loughrey MB;Fernández JA;Dombrowski Y;McArt DG;Dunne PD;McQuaid S;Gray RT;Murray LJ;Coleman HG;James JA;Salto-Tellez M;Hamilton PW
通讯作者:
Hamilton PW
影响因子:
16.6
作者:
MacParland SA;Liu JC;Ma XZ;Innes BT;Bartczak AM;Gage BK;Manuel J;Khuu N;Echeverri J;Linares I;Gupta R;Cheng ML;Liu LY;Camat D;Chung SW;Seliga RK;Shao Z;Lee E;Ogawa S;Ogawa M;Wilson MD;Fish JE;Selzner M;Ghanekar A;Grant D;Greig P;Sapisochin G;Selzner N;Winegarden N;Adeyi O;Keller G;Bader GD;McGilvray ID
通讯作者:
McGilvray ID
DOI:
10.1084/jem.20070432
发表时间:
2007-06-11
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Katschke KJ Jr;Helmy KY;Steffek M;Xi H;Yin J;Lee WP;Gribling P;Barck KH;Carano RA;Taylor RE;Rangell L;Diehl L;Hass PE;Wiesmann C;van Lookeren Campagne M
通讯作者:
van Lookeren Campagne M
影响因子:
9.8
作者:
Dominguez, Marlene;Rincon, Diego;Bataller, Ramon
通讯作者:
Bataller, Ramon
影响因子:
24.5
作者:
Forrest, EH;Evans, CDJ;Morris, AJ
通讯作者:
Morris, AJ